The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study
Abstract
AIMS: This study aimed to assess whether enalapril could improve cardioversion outcome and facilitate sinus rhythm maintenance after conversion of chronic atrial fibrillation (AF). METHODS AND RESULTS: Patients with chronic AF for more than 3 months were assigned to receive either amiodarone (200mg orally 3 times a day; group I: n=75) or the same dosage of amiodarone plus enalapril (10mg twice a day; group II: n=70) 4 weeks before scheduled external cardioversion. The end-point was the time to first recurrence of AF. In 125 patients (86.2%), AF was converted to sinus rhythm. Group II had a trend to a trend to a lower rate of immediate recurrence of AF than group I did (4.3% vs 14.7%, P=0.067). Kaplan-Meier analysis demonstrated a higher probability of group II remaining in sinus rhythm at 4 weeks (84.3% vs 61.3%, P=0.002) and at the median follow-up period of 270 days (74.3% vs 57.3%, P=0.021) than in group II. CONCLUSIONS: The addition of enalapril to amiodarone decreased the rate of immediate and subacute arrhythmia recurrences and facilitated subsequent long-term maintenance of sinus rhythm after cardioversion of persistent AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACE inhibitors or ARBs may reduce recurrent AF after cardioversion when coadministered with antiarrhythmic drug therapy compared with an antiarrhythmic drug alone.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [249]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Mouroux, A. L., Métayer, P. L., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 8,040
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Atrial Fibrillation Begets Atrial Fibrillation
WIJFFELS, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,500
Gelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins
Chen, S., HSIEH, M., TAI, C., Tsai, C.-F., Prakash, V. S., Yu, W., Hsu, T., Ding, Y.-A., & Chang, M.-S. (1999) · Circulation · doi:10.1161/01.cir.100.18.1879 · Cited by 1,442
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90363-8 · Cited by 1,096
Li, D., Shinagawa, K., Pang, L., Leung, T. K., Cardin, S., Wang, Z., & Nattel, S. (2001) · Circulation · doi:10.1161/hc4601.099402 · Cited by 702
Madrid, A. H., Bueno, M. G., Rebollo, J. M. G., Marín, I., Peña, G., Bernal, E., Rodriguez, A., Cano, L., Cano, J. M., Cabeza, P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000022665.18619.83 · Cited by 685
Electrical reversion of cardiac arrhythmias.
Lown, B. (1967) · Heart · doi:10.1136/hrt.29.4.469 · Cited by 664
Flagged first, then by citations
1 of the 45 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Furberg CD, Pasty BM, Manolio TA et al. Prevalence of atrial fibrillation in elderly subjects. Am J Cardiol 1994;74:236-41.
- Ewy G, Ulfers L, Hager WD et al. Response of atrial fibrillation to therapy: role of etiology and left atrial diameter. J Electrocardiol 1980;13:119-24.
Cited by
Sorted by citations
Items 201–293 of 293
Atrial fibrillation and congestive heart failure
Boyle, N. G., & Shivkumar, K. (2008) · Current Heart Failure Reports · doi:10.1007/s11897-008-0003-3 · Cited by 5
Renin-Angiotensin System and AtrialFibrillation:Understanding the Connection.
Disertori, M., & Quintarelli, S. (2011) · Europe PMC (PubMed Central) · doi:10.4022/jafib.398 · Cited by 5
Perindopril decreases P wave dispersion in patients with stage 1 hypertension
Özben, B., Sumerkan, M. C., Tanrikulu, A. M., Papila-Topal, N., Fak, A. S., & Toprak, A. C. (2009) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320309105199 · Cited by 4
Non-antiarrhythmic medications for atrial fibrillation: From bench to clinical practice
Guglin, M. E., Garcia, M., Yarnoz, M. J., & Curtis, A. B. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9204-7 · Cited by 4
Atrial Fibrillation in Congestive Heart Failure: Current Management
Boyle, N. G., & Shivkumar, K. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.09.016 · Cited by 4
Atrial fibrillation and heart failure
Santini, M., & Ricci, R. P. (2004) · EP Europace · doi:10.1016/j.eupc.2004.07.006 · Cited by 4
Management of atrial fibrillation in patients with heart failure: from drug therapy to ablation
Wongcharoen, W., & Chen, S. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.7.3.311 · Cited by 4
Atrial Fibrillation: Future Directions
Das, M. K., Yadav, A. V., & Zipes, D. P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-163-5_31 · Cited by 4
Gonna, H., & Gallagher, M. M. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0064-5 · Cited by 4
LIFE (losartan intervention for endpoint reduction in hypertension) study and its substudies
Borghi, C., & Ertek, S. (2007) · International Congress Series · doi:10.1016/j.ics.2007.03.014 · Cited by 3
Shamagian, L. G., Roman, A. V., Lamela, A. V., Veloso, P. R., García‐Acuña, J. M., & González‐Juanatey, J. R. (2005) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60669-5 · Cited by 3
Future Directions in Antiarrhythmic Drug Therapy for Atrial Fibrillation
Musco, S., Seltzer, J. H., & Kowey, P. R. (2006) · Future Cardiology · doi:10.2217/14796678.2.5.545 · Cited by 3
Endpunkte für Studien bei Patienten mit Vorhofflimmern
Kirchhof, P. F., Goette, A., Hindricks, G., Hohnloser, S., Kück, K., Meinertz, T., Ravens, U., Steinbeck, G., & Breithardt, G. (2007) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-007-0581-x · Cited by 3
Prevention of atrial fibrillation in hypertension
Aksnes, T. A., Flaa, A., Strand, A. H., & Kjeldsen, S. E. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0034-x · Cited by 3
Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling
Krishnamoorthy, S., & Lip, G. Y. H. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02083.x · Cited by 3
Prevención de la fibrilación auricular en los pacientes con insuficiencia cardiaca
Hernández‐Madrid, A., Moreno, G., Rondón, J., Marín, W. V., Castillo, M., Bernal, O., Tarancón, B., Amador, A., & Moro, C. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)75310-9 · Cited by 2
Use of Predictive Markers to Improve Cardiovascular Protection
Tocci, G., Paneni, F., Ponziani, B., & Volpe, M. (2007) · Future Cardiology · doi:10.2217/14796678.3.4.447 · Cited by 2
Hegbom, F., Tveit, A., Grundvold, I., Arnesen, H., & Smith, P. (2009) · EP Europace · doi:10.1093/europace/eup220 · Cited by 2
Hypertension and atrial fibrillation with emphasis on prevention
Aksnes, T. A., Kjeldsen, S. E., & Schmieder, R. E. (2009) · Blood Pressure · doi:10.1080/08037050903040744 · Cited by 2
Atrial fibrillation and hypertension
Aksnes, T. A., Kjeldsen, S. E., & Julius, S. (2009) · Cited by 2
Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
Sanoski, C. A., Kalus, J. S., & Johnson, S. G. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.s6-b.1 · Cited by 2
Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs.
Barrios, V., & Escobar, C. (2011) · Europe PMC (PubMed Central) · doi:10.4022/jafib.423 · Cited by 2
Hirt, L. S. (2012) · Cardiology Research · doi:10.4021/cr198w · Cited by 2
Atrial Fibrillation: Upstream Therapies
Kourliouros, A., Savelieva, I., Jahangiri, M., & Camm, A. J. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch36 · Cited by 2
Celık, T., & Iyısoy, A. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.120 · Cited by 2
Should aldosterone blockade be used beyond current indications in heart failure?
Smit, M. D., Gelder, I. C. V., Böhm, M., Neuberger, H., & van Veldhuisen, D. J. (2009) · Current Heart Failure Reports · doi:10.1007/s11897-009-0018-4 · Cited by 2
Camm, A. J., Kirchhof, P. F., Ernst, S., Gelder, I. C. V., Hindricks, G., Heidbüchel, H., Colonna, P., Goette, A., Hohloser, S. H., Kolh, P. H., et al. (2010) · Cited by 2
The role of the renin–angiotensin system blocking in the management of atrial fibrillation
Cliff, B., Younis, N., Hama, S., & Soran, H. (2012) · Journal of Drug Assessment · doi:10.3109/21556660.2012.672353 · Cited by 1
Atrial Fibrillation in Heart Failure Patients
Efremidis, M. (2009) · European Cardiology Review · doi:10.15420/ecr.2009.5.1.41 · Cited by 1
Atrial Fibrillation Revisited —With a Special Reference to Primary Prevention—
Aizawa, Y., Furushima, H., & Watanabe, H. (2007) · Journal of Arrhythmia · doi:10.1016/s1880-4276(07)80010-x · Cited by 1
Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion
Thomas, D., Yousef, Z. R., & Anderson, R. A. (2011) · ISRN Cardiology · doi:10.5402/2011/176834 · Cited by 1
Electrophysiological Basis of Atrial Fibrillation
Verheule, S., van Brakel, T. J., Harks, E. G. A., Greiser, M., & Allessie, M. A. (2008) · Wiley eBooks · doi:10.1002/9780470696354.ch5 · Cited by 1
Dai, S., Zhang, S., Chu, J., Guo, Y., Chen, K., & Yao, S. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.02.016 · Cited by 1
Deneke, T., Lemke, B., Lawo, T., Mügge, A., Horlitz, M., & Grewe, P. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.6.1047 · Cited by 1
Tveit, A., Grundvold, I., Olufsen, M., Seljeflot, I., Abdelnoor, M., Arnesen, H., & Smith, P. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.07.044 · Cited by 1
Elliott, W. J. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)05011-9 · Cited by 1
Role of renin–angiotensin system inhibitors in atrial fibrillation
Disertori, M., Latini, R., & Maggioni, A. P. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328343d3de · Cited by 1
Renin-angiotensin system inhibitors and atrial fibrillation.
Arbel, Y., & Glikson, M. (2005) · PubMed · Cited by 1
Celık, T., & Iyısoy, A. (2008) · Cited by 1
Richter, B., Gwechenberger, M., Kapitan, M., Marx, M., Lercher, P., & Goessinger, H. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.02.128 · Cited by 1
Lehto, M. (2009) · Työväentutkimus Vuosikirja
Efremidis, M., & Pappas, L. K. (2009) · Hospital chronicles/Hospital Chronicles
Auer, J. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Bluthochdruck und Herzrhythmusstörungen - eine gefährliche Kombination
Strohmer, B. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Altın, T., Gürlek, A., Özdöl, Ç., Kılıçkap, M., Dinçer, İ., Turhan, S., & Erol, Ç. (2007) · DOAJ (DOAJ: Directory of Open Access Journals)
Unveiling the Remodeled Atrium: Lessons from the Early Recurrence of Atrial Fibrillation
OBEL, O. A., & Joglar, J. A. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12323
Kjeldsen, S. E., Oparil, S., Hedner, T., & Narkiewicz, K. (2009) · Blood Pressure · doi:10.1080/08037050903040777
Steinberg, J. S., & Garikipati, N. V. (2010) · Cardiology · doi:10.1159/000320069
Martínez, V. B., & Pernas, D. N. (2007) · Hipertensión · doi:10.1016/s0212-8241(07)75764-x
Schuchert, A., & Meinertz, T. (2007) · Steinkopff eBooks · doi:10.1007/978-3-7985-1748-6_2
Nattel, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040853
Le rôle des médicaments non anti-arythmiques dans la prévention de la fibrillation auriculaire
Deharo, J.-C. (2009) · Annales de Cardiologie et d Angéiologie · doi:10.1016/s0003-3928(09)73400-6
When predicting atrial fibrillation, think 'scene of calamity'!
Limantoro, I., & Crijns, H. J. G. M. (2012) · EP Europace · doi:10.1093/europace/eus183
¿Es posible prevenir la fibrilacion auricular y sus complicaciones?
Marianella, S. R. (2012) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(12)70375-9
Benefits of angiotensin-II receptor blockers. Are we going beyond blood pressure control?
Volpe, M., & Tocci, G. (2006)
Durin, O., Pedrinazzi, C., & Inama, G. (2008) · Giornale italiano di cardiologia · doi:10.1714/675.7856
Kjeldsen, S. E., Aksnes, T. A., & Schmieder, R. E. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Rhythm control strategies for symptomatic atrial fibrillation
Hemels, M. E. W. (2007) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Gabrielli, L., Arnaíz, P., Mónica Acevedo, B., Enríquez, A., Salesa Barja, Y., Agloni, M., Samuel Córdova, A., & Aguilar, R. (2011) · Revista chilena de cardiología · doi:10.4067/s0718-85602011000200002
Lee, S. H., Hong, H. C., Kim, D. Y., Won, H. S., Yang, M. S., Kim, T. S., Seo, Y. Y., & Park, J. B. (2009) · The Korean Journal of Internal Medicine
German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association
Kirchhof, P. F., Auricchio, A., Bax, J. J., Crijns, H. J. G. M., Camm, A. J., Diener, H., Goette, A., Hindricks, G., Hohnloser, S. H., Kück, K., et al. (2007)
State of the Art Review Atrial Fibrillation: Basic Mechanisms, Remodeling and Triggers
Shiroshita-Takeshita, A., M, B. J. J., & Nattel, S. (2014)
Przeciwarytmiczne właściwości inhibitorów konwertazy angiotensyny
Szwoch, M., & Raczak, G. (2007) · Via Medica Journals
Qian, Y., Hanzhang, S., Luo, T.-X., Dongmin, W., Xiang, B., Jun, M., & Xiao, X. (2008) · Zhongguo xiong-xin xueguan waike linchuang zazhi
Dąbrowski, R., & Szwed, H. (2007) · PubMed
Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm.
Talajic, M. R., & Roy, D. (2005) · PubMed
Novikova, N. (2010) · CyberLeninK (CyberLeninka)
Nadciśnienie tętnicze i migotanie przedsionków — profilaktyka
Kjeldsen, S. E., Aksnes, T. A., & Schmieder, R. E. (2009) · Choroby Serca i Naczyń
Non-antiarrhythmic Therapies for Cardiac Arrhythmias
DEEDWANIA, P. C., & Lardizabal, J. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00084-3
Atrial Fibrillation, Heart Failure, and the Autonomic Nervous System
Zardkoohi, O., Grifoni, G., Padeletti, L., & Costea, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-24993-3_3
第2回 不整脈薬物治療フォーラム 基調講演II心房細動に対するupstream治療の展望
山下, 武. (2005) · 心臓 · doi:10.11281/shinzo1969.37.9_805
Prevention and Treatment of Atrial Fibrillation in Patients with Hypertension
Kjeldsen, S. E., Aksnes, T. A., Erdine, S. E., & Manolis, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-39599-9_9
Mancia, G., Laurent, S., Agabiti‐Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cífková, R., Clement, D. L., Coca, A., Dominiczak, A. F., et al. (2010) · Arterial Hypertension
Novikova, Т. N. (2010) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2010-16-4-423-428
Tatarskyi, B. A. (2007) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2007-13-3-197-201
Wpływ nadciśnienia tętniczego na strukturę i czynność lewego przedsionka
Prejbisz, M. O. K. C. S. K. W. W., & Pasierski, T. (2004) · Via Medica Journals
Таратухин, Е. О. (2012) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2012-5-71-73
Antiarrhythmic Properties of Non-Antiarrhythmic Drugs in Atrial Fibrillation: Upstream Therapy
Scridon, A., & Martínez‐Rubio, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-34893-9_7
Kirchhof, P. F., Goette, A., Hindricks, G., Hohnloser, S. H., Kück, K., Meinertz, T., Ravens, U., Steinbeck, G., & Breithardt, G. (2007) · Herzschrittmachertherapie + Elektrophysiologie
Serra, J. L. P., & Bendersky, M. (2009)
Pfeiffer, D., Salameh, A., & Hagendorff, A. (2006) · Steinkopff eBooks · doi:10.1007/3-7985-1632-4_11
Atrial remodelling in persistent atrial fibrillation: the potential role of aldosterone: Reply
Ueng, K.-C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.12.034
Self-citationUeng, K. (2004) · Evidence-based Cardiovascular Medicine · doi:10.1016/j.ebcm.2004.03.015
Self-citationATRIAL FIBRILLATION: THE STAGES OF TREATMENT AND DIAGNOSTIC MEASURES (literature review)
Salivonchyk, D. P. (2013) · Health and Ecology Issues · doi:10.51523/2708-6011.2013-10-3-2
Introduction to Atrial Fibrillation
Bollmann, A., & Lombardi, F. (2008) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-031-01633-2_1
Non-antiarrhythmic Drugs with Antiarrhythmic Properties
Scridon, A., Ivănescu, A. C., & Halațiu, V.-B. (2024) · Springer eBooks · doi:10.1007/978-3-031-74046-6_8
Calvo, N. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Cai, J., Li, Y., & Han, Y. (2026) · Cardiac Research · doi:10.1097/re9.0000000000000008
Metadata
- Authors
- Ueng, K.
- Affiliations
- Chung Shan Medical University Hospital (TW)
- Corresponding author
- Ueng, K
- ORCID
- Ueng, K
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-12
- Volume
- 24
- Issue
- 23
- Pages
- 2090-2098
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W1946485105
- Cited by
- 293
- References
- 45
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 7 · 2014: 6 · 2013: 13 · 2012: 9
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- enalapril, amiodarone, atrial fibrillation, external cardioversion, sinus rhythm maintenance, atrial fibrillation recurrence, long-standing persistent atrial fibrillation, combination anticoagulant therapy, ACE inhibitors
- MeSH terms
- Adolescent, Adult, Aged, Amiodarone, Angiotensin-Converting Enzyme Inhibitors, Anti-Arrhythmia Agents, Antihypertensive Agents, Atrial Fibrillation, Combined Modality Therapy, Drug Therapy, Combination, Electric Countershock, Enalapril, Humans, Long-Term Care, Middle Aged, Prospective Studies, Treatment Outcome, Disease-Free Survival, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
